NCT00322504

Brief Summary

To assess the efficacy of acupuncture treatment in reducing symptoms of anxiety in women recently diagnosed with cancer. • To assess the efficacy of acupuncture treatment on improving perceived quality of life in women recently diagnosed with cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable breast-cancer

Timeline
Completed

Started Jan 2006

Shorter than P25 for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2006

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 5, 2006

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 8, 2006

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2006

Completed
Last Updated

January 7, 2010

Status Verified

November 1, 2006

First QC Date

May 5, 2006

Last Update Submit

January 6, 2010

Conditions

Interventions

AccupuncturePROCEDURE

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Woman age 18 years or older excluding the need for parental/guardian permission.
  • Histologic diagnosis of breast cancer.
  • Having a minimum anxiety score of 1.75 on the Hopkins Symptom Checklist (HSCL) with sufficient English language proficiency for the investigators to make this determination.
  • Able to give informed consent.
  • Willingness to participate in the study and receive 10 acupuncture treatments in 5 weeks.
  • Ability to fill out questionnaires and communicate with the research staff

You may not qualify if:

  • Males with breast cancer
  • Psychoses or a major personality disorder
  • Current use of opiates,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of New Mexico

Albuquerque, New Mexico, 87114, United States

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Brian Shelley

    University of New Mexico

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 5, 2006

First Posted

May 8, 2006

Study Start

January 1, 2006

Study Completion

September 1, 2006

Last Updated

January 7, 2010

Record last verified: 2006-11

Locations